PolyPid COO’s Small Share Buy Signals Quiet Confidence as FDA Watch Turns Up on Antibiotic Pipeline
PolyPid insider purchase by COO Warshavsky Ori signals confidence in antibiotic pipeline, potential rally if FDA milestones hit.
3 minutes to read
PolyPid Ltd
PolyPid Ltd. Files Director Nir’s Multi‑Year Stock‑Option Grants, No Current Shares in Play
PolyPid’s latest Form 3 shows no immediate dilution, only long‑term option grants for director Nir, signaling steady insider confidence and future growth potential.
3 minutes to read
PolyPid’s CEO and Founder Ramp Up Insider Buying Ahead of FDA‑Dated Antibiotic Push
PolyPid insider stock options and CEO buying signal confidence in FDA‑approved antibiotic D‑PLEX100, boosting investor optimism while highlighting risk‑adjusted valuation.
3 minutes to read